Regulation of chromatin states during progression to NEPC

Last updated date

9:44am

We are currently investigating how chromatin states are modulated during the progression from castration-resistant prostate cancer (CRPC) to neuroendocrine prostate cancer (NEPC). We utilize CRISPR-mediated gene editing tools coupled with next-generation sequencing approaches to understand changes to chromatin accessibility and epigenetic modifications in the genome.

Weill Cornell Medicine Brady Lab 1300 York Ave.
Lab: C-320
Office: B-317
New York, NY 10065 Phone: (646) 962-8372